Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07137793) titled 'Clinical Study to Evaluate The Cardioprotective Effect of Pentoxifylline Against Doxorubicin Induced Cardiotoxicity in Breast Cancer Patients' on Aug. 15.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: Double (Participant, Care Provider).
Primary Sponsor: Tanta University
Condition:
Doxorubicin Induced Cardiotoxicity
Breast Cancer
Intervention:
Drug: Pentoxifylline 400mg plus chemotherapy
Recruitment Status: Recruiting
Phase: Phase 2
Date of First Enrollment: May 25, 2025
Target Sample Size: 46
Countries of...